MDM2 and prostate cancer: PC-3 cells, which do not express AR, responded with elevated levels of TM4SF3 in response to MDM2 inhibition, but this had no significant effect on cell proliferation, clearly demonstrating that TM4SF3 without endogenous AR does not affect the viability of prostate cancer cells.